PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cardiology, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon.\', \'Internal Medicine, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon.\', \'Department of Pharmacy Practice, Lebanese American University School of Pharmacy, Byblos, Lebanon.\', \'Lebanese American University School of Medicine, Byblos, Lebanon.\', \'Lebanese University Faculty of Pharmacy, Hadath, Lebanon.\', \'University of Nicosia Medical School, Nicosia, Cyprus.\', \'Cardiology, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon gghanemresearch@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e00178510.1136/openhrt-2021-001785
?:hasPublicationType
?:journal
  • Open heart
is ?:pmid of
?:pmid
?:pmid
  • 34611018
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.281
?:rankingScore_hIndex
  • 15
is ?:relation_isRelatedTo_publication of
?:title
  • Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all